Antibacterial Effect of Eight Probiotic Strains of Bifidobacterium against Pathogenic Staphylococcus aureus and Pseudomonas aeruginosa

Yae Jin Choi; Hea Soon Shin

doi:10.4167/jbv.2021.51.3.128

All Issue

2021 Vol.51, Issue 3 Preview Page Next Page

Original Article

Antibacterial Effect of Eight Probiotic Strains of Bifidobacterium against Pathogenic Staphylococcus aureus and Pseudomonas aeruginosa

30 September 2021. pp. 128-137

PDF XML

Abstract

Bifidobacterium strains inhibit growth or cell adhesion of pathogenic bacteria and against multidrug-resistant bacteria. Furthermore, when combined with certain antibiotics, probiotics can boost their antibacterial activity. The objective of present report was to evaluate the antibacterial effect of Bifidobacterium spp. In the first part of the investigation, we evaluated the antibacterial activities of viable and inactivated cells, from a total of 12 Bifidobacterium species, on the growth of three different common pathogens associated with multi-drug resistance such as Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Eenterococcus faecalis. Also, eight strains of sonication-inactivated Bifidobacteria exhibited antibacterial activity against S. aureus and P. aeruginosa. Additionally, eight viable Bifidobacterium strains exhibited antibacterial activity on the growth of pathogenic species. Therefore, we observed the antimicrobial activity, of Bifidobacteria against pathogenic bacteria, on the solid medium utilizing the agar well diffusion method. Some Bifidobacterium supernatants such as B. longum and B. pseudocatenulatum, showed synergism with the antibacterial activity of antibiotics. The results exhort that Bifidobacteria could be employed as an effective control for nosocomial pathogenic bacteria, and reduce the risk of the development of S. aureus and P. aeruginosa infection. The present authors propose that Bifidobacteria might be a useful probiotic microorganism, for combining modality with antibiotics, without adverse effects.

Keywords

Bifidobacteria

Antibacterial

Probiotics

Antibiotics

References

Gould K. Antibiotics: From prehistory to the present day. J Antimicrob Chemother 2016;71:572-5.

10.1093/jac/dkv48426851273

Kraemer SA, Ramachandran A, Perron GG. Antibiotic pollution in the environment: From microbial ecology to public policy. Microorganisms 2019;7:180.

10.3390/microorganisms706018031234491PMC6616856

Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science 2016;352:544-5.

10.1126/science.aad935827126037PMC4939477

Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989;66:365-78.

10.1111/j.1365-2672.1989.tb05105.x

Anukam KC, Reid G, ARM C. Probiotics: 100 years (1997-2007) after Elie Metchnikoff's observation. Communicating current research and educational topics and trends in applied microbiology 2007;1:466-74.

Mastromarino P, Cacciotti F, Masci A, Mosca L. Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: Role of cell wall associated components. Anaerobe 2011;17:334-6.

10.1016/j.anaerobe.2011.04.02221621625

Shadnoush M, Shaker HR, Mehrabi Y, Delpisheh A, Alipoor E, Faghfoori Z, et al. Probiotic yogurt affects pro- and anti-inflammatory factors in patients with inflammatory bowel disease. Iran J Pharm Res 2013;12:929-36.

Isolauri E, Kirfavainen PV, Salminen S. Probiotics a role in the treatment of intestinal infection and inflammation? Gut 2002;50:54-9.

10.1136/gut.50.suppl_3.iii5411953334PMC1867676

Esaiassen E, Hjerde E, Cavanagh JP, Pedersen T, Andresen JH, Rettedal SI, et al. Effects of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants. Front Pediatr 2018;6:347.

10.3389/fped.2018.0034730505830PMC6250747

Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007;137:812S-8S.

10.1093/jn/137.3.812S17311980

Sawada D, Sugawara T, Ishida Y, Aihara K, Aoki Y, Fujiwara S, et al. Effect of continuous ingestion of a beverage prepared with lactobacillus gasseri cp2305 inactivated by heat treatment on the regulation of intestinal function. Food Res Int 2016;79:33-9.

10.1016/j.foodres.2015.11.032

Cuevas-González PF. Liceaga AM, Aguilar-Toalá J. Postbiotics and paraprobiotics: From concepts to applications. Food Res Int 2020;136:109502.

10.1016/j.foodres.2020.10950232846581

Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 2010;23:37-46.

10.1017/S095442241000009020403231

Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI, Shkoporov AN. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol Immunol 2012;56:27-39.

10.1111/j.1348-0421.2011.00398.x22040047

Yang J, Yang H. Effect of Bifidobacterium breve in combination with different antibiotics on Clostridium difficile. Front Microbiol 2018;9:2953.

10.3389/fmicb.2018.0295330564210PMC6288195

Pessi T, Sütas Y, Saxelin M, Kallioinen H, Isolauri E. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 1999;65:4725-8.

10.1128/AEM.65.11.4725-4728.199910543777PMC91635

CLSI. Performance standards for antimicrobial susceptibility testing; twenty-eighth informational supplement. CLSI document M100-S28. Wayne, PA: Clinical and Laboratory Standards Institute, 2018.

Ventola CL. The antibiotic resistance crisis: Part 2: management strategies and new agents. PT 2015;40:344-52.

Karska-Wysocki B, Bazo M, Smoragiewicz W. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiol Res 2010;165:674-86.

10.1016/j.micres.2009.11.00820116228

Layus BI, Gerez CL, Rodriguez AV. Antibacterial activity of Lactobacillus plantarum CRL759 against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Arab J Sci Eng 2020;45:4503-10.

10.1007/s13369-020-04491-w

AL-Saadi ZN. In vitro antagonistic activity of Bifidobacterium breve isolated from breast-fed infants human gastrointestinal microflora against two clinical strains of Staphylococcus aureus (MRSA and MSSA). J Advances in Biology & Biotechnology 2016;10:1-9.

10.9734/JABB/2016/28724

Lee DK, Kim MJ, Kang JY, Park JE, Shin HS, Ha NJ, et al. Probiotic with antimicrobial activity against multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. KJ Microbiology 2013;49:245-52.

Corr SC, Gahan CC, Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 2008;52:2-12.

10.1111/j.1574-695X.2007.00359.x18081850

Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MP, Rashid MU, et al. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio 2015;6:e01693-15.

10.1128/mBio.01693-1526556275PMC4659469

Jorjão AL, de Oliveira FE, Leão MV, Carvalho CA, Jorge AO, de Oliveira LD. Live and heat-killed Lactobacillus rhamnosus ATCC 7469 may induce modulatory cytokines profiles on macrophages RAW 264.7. Scientific World Journal 2015;2015:716749.

10.1155/2015/71674926649329PMC4663741

Geraldo BMC, Batalha MN, Milhan NVM, Rossoni RD, Scorzoni L, Anbinder AL. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis. J Periodontal Res 2020;55:215-20.

10.1111/jre.1270431691977

Information

Publisher :The Korean Society for Microbiology and The Korean Society of Virology
Publisher(Ko) :대한미생물학회‧대한바이러스학회
Journal Title :JOURNAL OF BACTERIOLOGY AND VIROLOGY
Volume : 51
No :3
Pages :128-137
Received Date : 2021-08-02
Revised Date : 2021-09-17
Accepted Date : 2021-09-23
DOI :https://doi.org/10.4167/jbv.2021.51.3.128

JOURNAL OF BACTERIOLOGY AND VIROLOGY ISSN:1598-2467(Print) 2093-0429(Online)

All Issue